Trial intelligence / Profile preview

Tadalafil for Priapism in Sickle Cell Anemia

NCT00538564Phase 2Withdrawn

Sponsor
Johns Hopkins University
Start
Nov 2006
Primary completion
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tadalafil in Priapism, sponsored by Johns Hopkins University. Planned start Nov 2006; status: withdrawn.

02

Drugs

tadalafil
03

Conditions

Priapism

Beyond the preview

Go deeper on NCT00538564.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00538564.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call